Karamjit S. Jandu

GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor

Alastair D. Reith, Paul Bamborough, Karamjit S. Jandu et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 149 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +11

Structure-activity relationships of antifilarial antimycin analogs: a multivariate pattern recognition study

David L. Selwood, David J. Livingstone, John C.W. Comley et al. · Journal of Medicinal Chemistry · 1990 · 127 citations

Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists

Adrian Hall, Stephen J. Atkinson, Susan H. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 42 citations · Full text

Biochemistry, Functional Selectivity, Medicine +4

Discovery of 4-[3-(<i>trans</i>-3-Dimethylaminocyclobutyl)-1<i>H</i>-indol-5-ylmethyl]- (4<i>S</i>)-oxazolidin-2-one (4991W93), a 5HT_1B/1DReceptor Partial Agonist and a Potent Inhibitor of Electrically Induced Plasma Extravasation

Karamjit S. Jandu, Vikki Barrett, Michael Brockwell et al. · Journal of Medicinal Chemistry · 2001 · 41 citations · Full text

Potent Inhibitor, Pharmacotherapy, Experimental Pharmacology +17

Synthesis and biological evaluation of the L-enantiomer of 2′-deoxy-5-ethyl-4′-thiouridine

David L. Selwood, Keith Carter, Robert J. Young et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 24 citations

Bioorganic Chemistry, Organic Chemistry, Biological Evaluation +4